相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency
Gery Gerritsen et al.
JOURNAL OF LIPID RESEARCH (2008)
Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants - The GOLDN study
Chao-Qiang Lai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Hypertriglyceridemia and cardiovascular risk reduction
Terry A. Jacobson et al.
CLINICAL THERAPEUTICS (2007)
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors
Philippe Gervois et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Sorting out the roles of PPARα in energy metabolism and vascular horneostasis
P Lefebvre et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants
I Grosskopf et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase
M Merkel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia
CP Oliva et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
FG Schaap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators
N Vu-Dac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
LA Pennacchio et al.
SCIENCE (2001)
分享论文
